uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Comparison of [177Lu-DOTA0,Tyr3]-Octreotate and [177Lu-DOTA0,Tyr3]-Octreotide for Receptor-Mediated Radiation Therapy of the Xenografted Human Midgut Carcinoid Tumor GOT1
Show others and affiliations
2008 (English)In: Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, E-ISSN 1557-8852, Vol. 23, no 1, 114-120 p.Article in journal (Refereed) Published
Abstract [en]

The aim of this study was to compare the tumor uptake versus time and the tumor response in nude mice transplanted with a human midgut carcinoid (GOT1), when treated with either [177Lu-DOTA0,Tyr3]-octreotide or [177Lu-DOTA0,Tyr3]-octreotate and to evaluate if plasma chromogranin A (P-CgA) was a reliable marker of tumor response. The tumor uptake and retention of activity of a single intravenous (i.v.) dose (15 MBq) of [177Lu-DOTA0,Tyr3]-octreotate or [177Lu-DOTA0,Tyr3]-octreotide were compared in nude mice xenografted with GOT1. The activity concentration 24 hours after injection was significantly higher in animals given [177Lu-DOTA0,Tyr3]-octreotate versus [177Lu-DOTA0,Tyr3]-octreotide (16% ± 1.4% of injected activity per gram [%IA/g] vs. 8.1% ± 2.1% IA/g, mean ± standard error of the mean) (p = 0.00061). The mean absorbed dose was higher in animals given [177Lu-DOTA0,Tyr3]-octreotate (46 ± 4.3 vs. 17 ± 3.4 Gy). The reduction of tumor volume was accordingly more prominent in animals given [177Lu-DOTA0,Tyr3]-octreotate than in animals given [177Lu-DOTA0,Tyr3]-octreotide (p = 0.003). The mean tumor volume for animals given [177Lu-DOTA0,Tyr3]-octreotate was reduced to 3% of its initial value. P-CgA values were strongly correlated with tumor volume. Octreotate seems to be a more suitable somatostatin analog than octreotide for receptor-mediated radiation therapy. P-CgA is a simple, accurate method for the estimation of tumor response in this animal model.

Place, publisher, year, edition, pages
2008. Vol. 23, no 1, 114-120 p.
Keyword [en]
octreotate, octreotide, somatostatin receptor, carcinoid, chromogranin A
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-152597DOI: 10.1089/cbr.2007.0421ISI: 000254025100012OAI: oai:DiVA.org:uu-152597DiVA: diva2:413531
Available from: 2011-04-28 Created: 2011-04-28 Last updated: 2013-07-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Stridsberg, Mats
By organisation
Biochemical endocrinology
In the same journal
Cancer Biotherapy and Radiopharmaceuticals
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 173 hits
ReferencesLink to record
Permanent link

Direct link